DEFINING AND EVALUATING IN-HOME DISPOSAL SYSTEMS FOR OPIOID ANALGESICS
DAY 1: JUNE 26, 2023
| 9:00 a.m. |
Welcome and Opening Remarks |
|
ALASTAIR WOOD, Workshop Co-Chair |
|
|
Professor of Medicine Emeritus |
|
|
Vanderbilt University School of Medicine |
|
| 9:05 a.m. |
FDA Authority for In-Home Opioid Disposal |
|
MARTA SOKOLOWSKA |
|
|
Deputy Center Director for Substance Use and Behavioral Health |
|
|
Center for Drug Evaluation and Research |
|
|
Food and Drug Administration |
|
| 9:15 a.m. |
Fireside Chat: Life Cycle of Prescribed Opioids |
|
ROBERT HOFFMAN, Speaker |
|
|
Professor, Department of Emergency Medicine |
|
|
New York University Grossman School of Medicine |
|
BETH McGINTY, Workshop Co-Chair, Moderator |
|
|
Chief, Division of Health Policy and Economics |
|
|
Professor, Department of Population Health Sciences |
|
|
Weill Cornell Medicine |
SESSION I — ENVISIONING DISPOSAL SYSTEMS TO REMOVE OPIOIDS FROM THE HOME
Session Objectives:
| 9:55 a.m. |
Presentation |
|
LAURA BIX |
|
|
Assistant Dean for Teaching, Learning and Academic Analytics |
|
|
Michigan State University College of Agriculture & Natural Resources |
|
| 10:15 a.m. |
Panel Discussion |
|
RUCHI FITZGERALD, Moderator |
|
|
Assistant Professor, Rush University |
|
|
Service Chief of Inpatient Addiction Medicine, PCC Community Wellness Center |
|
|
Panelists |
|
|
Health Care Innovation Perspective |
|
|
ANISH AGARWAL |
|
|
Assistant Professor of Emergency Medicine |
|
|
University of Pennsylvania Perelman School of Medicine |
|
Behavioral Science Perspective |
|
|
KATHLEEN EGAN |
|
|
Assistant Professor, Health Education and Promotion |
|
|
East Carolina University College of Health and Human Performance |
|
|
Consumer/Patient Perspective |
|
|
LINDSAY BARAN |
|
|
Senior Research Director |
|
|
Health Care Evaluation Department |
|
|
NORC at the University of Chicago |
|
|
Opioid Stewardship Perspective |
|
|
LYEN HUANG |
|
|
Assistant Professor of Surgery |
|
|
University of Utah Spencer Fox Eccles School of Medicine |
|
| 11:15 a.m. |
BREAK (30 mins) |
SESSION II — REGULATORY LANDSCAPE FOR HOUSEHOLD OPIOID DISPOSAL
Session Objectives:
| 11:45 a.m. |
Presentation |
|
HANZ ATIA |
|
|
Associate, Policy and Programs |
|
|
Product Stewardship Institute |
|
| 12:05 p.m. |
Panel Discussion |
|
LEWIS GROSSMAN, Moderator |
|
|
Professor |
|
|
American University Washington College of Law |
|
Panelists |
|
|
EPA Regulatory Perspective |
|
|
KRISTIN FITZGERALD |
|
|
Environmental Protection Specialist |
|
|
Office of Resource Conservation and Recovery |
|
|
Environmental Protection Agency |
|
|
State Drug Disposal Policy Perspective |
|
|
MARY KELLINGTON |
|
|
Safe Medication Return Program Manager |
|
|
Washington State Department of Health |
|
|
FDA Regulatory Perspective |
|
|
PATRICK RAULERSON |
|
|
Senior Regulatory Counsel |
|
|
Center for Drug Evaluation and Research |
|
|
Food and Drug Administration |
|
|
Former Federal Opioid Policy Perspective |
|
|
UTTAM DHILLON |
|
|
Partner |
|
|
Michael Best & Friedrich LLP |
|
| 1:05 p.m. |
LUNCH BREAK (55 mins) |
SESSION III — SCIENTIFIC CONSIDERATIONS FOR IN-HOME OPIOID DISPOSAL
Session Objectives:
| 2:00 p.m. |
Presentation |
|
MARGARET SHIELD |
|
|
Owner and Principal |
|
|
Community Environmental Health Strategies LLC |
|
| 2:20 p.m. |
Panel Discussion |
|
JESSICA YOUNG, Moderator |
|
|
Chief, Recycling and Generator Branch |
|
|
Environmental Protection Agency |
|
|
Panelists |
|
|
Opioid Chemistry Perspective |
|
|
ANDREW COOP |
|
|
Professor, Pharmaceutical Sciences |
|
|
Associate Dean for Academic Affairs |
|
|
University of Maryland School of Pharmacy |
|
|
Toxicology Perspective |
|
|
KAITLYN BROWN |
|
|
Clinical Managing Director |
|
|
America’s Poison Centers |
|
|
FDA Perspective |
|
|
MARTA SOKOLOWSKA |
|
|
Deputy Center Director for Substance Use and Behavioral Health |
|
|
Center for Drug Evaluation and Research |
|
|
Food and Drug Administration |
|
|
Environmental Chemistry Perspective |
|
|
PAUL BRADLEY |
|
|
Project Lead |
|
|
Drinking-Water and Wastewater Infrastructure Integrated Science Team |
|
|
Ecosystems Mission, Environmental Health Program |
|
|
U.S. Geological Survey |
|
| 3:20 p.m. |
BREAK (30 mins) |
SESSION IV — REAL-WORLD USE AND IMPLEMENTATION OF IN-HOME OPIOID DISPOSAL SYSTEMS
Session Objectives:
| 3:50 p.m. |
Presentation |
|
CHAD BRUMMETT |
|
|
Bert N. LaDu Professor of Anesthesiology |
|
|
Co-Director, Opioid Research Institute |
|
|
Co-Director, Opioid Prescribing Engagement Network |
|
|
University of Michigan Medical School |
|
| 4:10 p.m. |
Panel Discussion |
|
MARK BICKET, Moderator |
|
|
Assistant Professor |
|
|
Director, Pain & Opioid Research |
|
|
Department of Anesthesiology |
|
|
Institute for Healthcare Policy and Innovation |
|
|
University of Michigan Medical School |
|
|
Panelists |
|
|
Implementation Perspective |
|
|
ANDREA TSATOKE |
|
|
Injury Prevention Specialist |
|
|
Indian Health Service, Headquarters |
|
|
Program Evaluation Perspective |
|
|
ELEANOR T. LEWIS |
|
|
Deputy Director, Program Evaluation & Resource Center |
|
|
U.S. Department of Veterans Affairs |
|
REMS Design and Implementation Perspective |
|
|
JAMES SHAMP |
|
|
Vice President for Data Intelligence & Program Analytics |
|
|
United BioSource LLC |
|
|
Retail Pharmacy Perspective |
|
|
KEVIN NICHOLSON |
|
|
Vice President, Public Policy, Regulatory, and Legal Affairs |
|
|
National Association of Chain Drug Stores |
|
|
Behavioral Science and Communication Perspective |
|
|
TAMAR KRISHNAMURTI |
|
|
Assistant Professor, Medicine and Clinical and Translational Science |
|
|
Department of Medicine Center for Research on Health Care |
|
|
University of Pittsburgh |
|
| 5:20 p.m. |
Summary Remarks |
|
ALASTAIR WOOD, Workshop Co-Chair |
|
| 5:30 p.m. |
DAY 1 ADJOURN |
DAY 2: JUNE 27, 2023
| 8:30 a.m. |
Welcome and Opening Remarks |
|
BETH McGINTY, Workshop Co-Chair |
|
| 8:50 a.m. |
Risk Evaluation and Mitigation Strategies: An Overview |
|
LYNN MEHLER |
|
|
Practice Area Lead, Pharmaceuticals & Biotechnology |
|
|
Hogan Lovells LLP |
SESSION V — THE ROLE OF IN-HOME OPIOID DISPOSAL
Session Objectives:
| 9:15 a.m. |
Presentation |
|
KATHLEEN EGAN |
|
|
Assistant Professor, Health Education and Promotion |
|
|
East Carolina University College of Health and Human Performance |
|
| 9:35 a.m. |
Panel Discussion |
|
ROBERT MORONES, Moderator |
|
|
Injury Prevention Specialist |
|
|
Indian Health Service (Phoenix Area) |
|
|
U.S. Department of Health and Human Services |
|
|
Panelists |
|
|
Pediatric Injury Prevention Perspective |
|
|
CHRISTOPHER GAW |
|
|
Pediatric Emergency Medicine Fellow |
|
|
Associate Fellow, Center for Injury Research and Prevention |
|
|
Children’s Hospital of Philadelphia |
|
|
Overdose Prevention Perspective |
|
|
JEFF HORWITZ |
|
|
Chief Executive Officer |
|
|
SAFE Project |
|
|
Harm Reduction Perspective |
|
|
SUSAN SHERMAN |
|
|
Bloomberg Professor of American Health |
|
|
Department of Health, Behavior and Society |
|
|
Johns Hopkins Bloomberg School of Public Health |
|
|
National Institute on Drug Abuse Perspective |
|
|
WILSON COMPTON |
|
|
Deputy Director, National Institute on Drug Abuse |
|
|
National Institutes of Health |
|
| 10:45 a.m. |
BREAK (30 mins) |
SYNTHESIS DISCUSSION
Purpose:
| 11:15 a.m. |
Moderated Panel Discussion |
|
ALASTAIR WOOD, Workshop Co-Chair, Moderator |
|
|
Panelists |
|
|
Pharmaceutical Sciences Perspective |
|
|
ANDREW COOP |
|
|
Professor, Pharmaceutical Sciences |
|
|
Associate Dean for Academic Affairs |
|
|
University of Maryland School of Pharmacy |
|
|
Implementation Perspective |
|
|
MARK BICKET |
|
|
Assistant Professor |
|
|
Director, Pain & Opioid Research |
|
|
Department of Anesthesiology |
|
|
Institute for Healthcare Policy and Innovation |
|
|
University of Michigan Medical School |
|
|
Overdose Prevention Perspective |
|
|
JEFF HORWITZ |
|
|
Chief Executive Officer |
|
|
SAFE Project |
|
|
Human-Centered Design Perspective |
|
|
LAURA BIX |
|
|
Assistant Dean for Teaching, Learning and Academic Analytics |
|
|
Michigan State University College of Agriculture & Natural Resources |
|
|
Food and Drug Administration Perspective |
|
|
PATRICK RAULERSON |
|
|
Senior Regulatory Counsel |
|
|
Center for Drug Evaluation and Research |
|
|
Food and Drug Administration |
| 12:15 p.m. |
Panel Discussion with Audience Engagement |
| 12:45 p.m. |
Closing Remarks |
|
BETH McGINTY, Workshop Co-Chair |
|
| 1:00 p.m. |
DAY 2 ADJOURN |